The global Facial Injectables Market is expected to reach USD
17.2 billion by 2025, according to a new report by Grand View Research, Inc.
The market is expected to exhibit lucrative growth during the forecast period,
owing to advancements in facial rejuvenation procedures and increasing importance
of medical aesthetics across the globe.
Development in products & procedures, as well as
change in patient demographics is helping dermatologists and physicians treat
multiple facial areas. These advancements help dermatologists or physicians
develop customized treatment for patients and facilitate use of combination
products to obtain better outcomes. All these factors are expected to assist in
the market growth over the forecast period. Augmented products such as
Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) fillers are used in
combination to improve outcomes, especially in the lower face procedures. HA
fillers are mostly preferred by physicians due to their better acceptance (few
instances of hypersensitivity reactions), biodegradable nature, & high
viscosity as well as for the longevity they provide to the restored volume.
Minimally invasive surgery, an advanced medical
technology, is used for facial rejuvenation, endoscopy, laparoscopy,
arthroscopy and other procedures. This procedure is gaining popularity over
time owing to faster recovery, low instances of postsurgery infections, lower
pain, reduced scarring, and high accuracy & maximum benefits. For instance,
as per International Society of Aesthetic Plastic Surgery (ISAPS), more than
20.0 million surgical and nonsurgical cosmetic procedures were performed
worldwide in 2014.The number of HA-based surgeries performed in 2014 was
2,690,633, which increased to 2,865,086 in 2015, which is thereby expected to
contribute to the growth of this space over the forecast period.
Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/facial-injectables-industry
http://www.grandviewresearch.com/industry-analysis/facial-injectables-industry
Further key findings from the study
suggest:
- The
hyaluronic acid segment held a lucrative share in 2016 and is expected to
grow at a significant rate over the forecast period owing to increasing
preference for combination treatments such as hyaluronic acid with BoNTA.
- The BoNTA
segment is anticipated to witness the fastest growth over the forecast
period due to increasing application in aesthetics and therapeutics
- The
aesthetics segment is expected to dominate the market during the forecast
period owing to increasing expenditure on aesthetic procedures coupled
with rising beauty consciousness among consumers
- North
America is expected to dominate the facial injectables market over the
forecast period due to growing geriatric population base, increasing
consumer disposable income, and surge in number of facial procedures in
the region
- Some of
the key players in facial injectables market are ALLERGAN; Ipsen; Merz
Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage
BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium
Medical Technologies Inc.; and Galderma S.A.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment